KR101858421B1 - 면역 질환의 예방 및/또는 치료제 - Google Patents

면역 질환의 예방 및/또는 치료제 Download PDF

Info

Publication number: KR101858421B1
Authority: KR; South Korea
Prior art keywords: group; amino; pyrimidine; oxazol; carboxamide
Prior art date: 2015-01-30

Application number

KR1020177018431A

Other languages

English (en)

Korean (ko)

Other versions

KR20170083640A (ko

Inventor

후미히토 호소이

요시노리 나카치

다이스케 가지와라

Original Assignee

다이호야쿠힌고교 가부시키가이샤

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-01-30

Filing date

2016-01-29

Publication date

2018-05-15

2016-01-29 Application filed by 다이호야쿠힌고교 가부시키가이샤 filed Critical 다이호야쿠힌고교 가부시키가이샤

2017-07-18 Publication of KR20170083640A publication Critical patent/KR20170083640A/ko

2018-05-15 Application granted granted Critical

2018-05-15 Publication of KR101858421B1 publication Critical patent/KR101858421B1/ko

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- Y10S514/825—

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

KR1020177018431A 2015-01-30 2016-01-29 면역 질환의 예방 및/또는 치료제 KR101858421B1 (ko)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2015017386		2015-01-30
JPJP-P-2015-017386		2015-01-30
PCT/JP2016/052732 WO2016121953A1 (ja)	2015-01-30	2016-01-29	免疫疾患の予防及び／又は治療剤

Publications (2)

Publication Number	Publication Date
KR20170083640A KR20170083640A (ko)	2017-07-18
KR101858421B1 true KR101858421B1 (ko)	2018-05-15

Family

ID=56543555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020177018431A KR101858421B1 (ko)	2015-01-30	2016-01-29	면역 질환의 예방 및/또는 치료제

Country Status (21)

Country	Link
US (1)	US9782412B2 (pl)
EP (1)	EP3120852B1 (pl)
JP (1)	JP6093485B2 (pl)
KR (1)	KR101858421B1 (pl)
CN (2)	CN113768935B (pl)
AU (1)	AU2016213030B2 (pl)
BR (1)	BR112017016278B1 (pl)
CA (1)	CA2975372C (pl)
DK (1)	DK3120852T3 (pl)
ES (1)	ES2734364T3 (pl)
HU (1)	HUE045532T2 (pl)
MX (1)	MX2017009863A (pl)
MY (1)	MY197518A (pl)
PH (1)	PH12017501336A1 (pl)
PL (1)	PL3120852T3 (pl)
PT (1)	PT3120852T (pl)
RU (1)	RU2705154C2 (pl)
SG (1)	SG11201704430SA (pl)
TR (1)	TR201910158T4 (pl)
TW (1)	TWI638817B (pl)
WO (1)	WO2016121953A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2667247T3 (es) *	2015-01-30	2018-05-10	Taiho Pharmaceutical Co., Ltd.	Sal novedosa de compuesto de pirimidina condensado y cristal del mismo
CN114828856B (zh) *	2019-12-19	2024-11-05	大鹏药品工业株式会社	以稠合嘧啶化合物为有效成分的治疗剂
CN112209894B (zh) *	2020-10-23	2023-06-06	贵州医科大学	5-芳基取代2-氨基苯并恶唑类衍生物、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1968979A2 (en) *	2005-12-08	2008-09-17	Abbott Laboratories	9-membered heterobicyclic compounds as inhibitors of protein kinases
CN101616673A (zh) *	2006-09-13	2009-12-30	武田药品工业株式会社	2-[6-(3-氨基-哌啶-1-基)-3-甲基-2,4-二氧代-3,4-二氢-2h-嘧啶-1-基甲基]-4-氟-苄腈的用途
CA2668286C (en) *	2006-11-03	2014-09-16	Pharmacyclics, Inc.	Bruton's tyrosine kinase activity probe and method of using
JP2009235057A (ja) *	2007-10-31	2009-10-15	Santen Pharmaceut Co Ltd	血管新生阻害活性を有する新規インドール誘導体
AU2009262068C1 (en)	2008-06-27	2015-07-02	Celgene Car Llc	Heteroaryl compounds and uses thereof
US8338439B2 (en) *	2008-06-27	2012-12-25	Celgene Avilomics Research, Inc.	2,4-disubstituted pyrimidines useful as kinase inhibitors
EP2731612A4 (en)	2011-07-13	2015-04-08	Pharmacyclics Inc	BRUTON TYROSINE KINASE HEMMER
CA2854093C (en) *	2012-01-19	2016-07-05	Taiho Pharmaceutical Co., Ltd.	3,5-disubstituted alkynylbenzene compound and salt thereof
JP2015526520A (ja) *	2012-08-31	2015-09-10	プリンシピアバイオファーマインコーポレイテッド	Ｉｔｋ阻害剤としてのベンズイミダゾール誘導体
JP6035423B2 (ja) *	2013-08-12	2016-11-30	大鵬薬品工業株式会社	新規な縮合ピリミジン化合物又はその塩

2016
- 2016-01-29 MX MX2017009863A patent/MX2017009863A/es unknown
- 2016-01-29 DK DK16743556.9T patent/DK3120852T3/da active
- 2016-01-29 AU AU2016213030A patent/AU2016213030B2/en active Active
- 2016-01-29 KR KR1020177018431A patent/KR101858421B1/ko active IP Right Grant
- 2016-01-29 EP EP16743556.9A patent/EP3120852B1/en active Active
- 2016-01-29 PL PL16743556T patent/PL3120852T3/pl unknown
- 2016-01-29 CN CN202111054911.9A patent/CN113768935B/zh active Active
- 2016-01-29 TR TR2019/10158T patent/TR201910158T4/tr unknown
- 2016-01-29 SG SG11201704430SA patent/SG11201704430SA/en unknown
- 2016-01-29 CN CN201680007390.2A patent/CN107206001B/zh active Active
- 2016-01-29 PT PT16743556T patent/PT3120852T/pt unknown
- 2016-01-29 BR BR112017016278-4A patent/BR112017016278B1/pt active IP Right Grant
- 2016-01-29 RU RU2017127126A patent/RU2705154C2/ru active
- 2016-01-29 MY MYPI2017701813A patent/MY197518A/en unknown
- 2016-01-29 TW TW105102962A patent/TWI638817B/zh active
- 2016-01-29 JP JP2016533731A patent/JP6093485B2/ja active Active
- 2016-01-29 HU HUE16743556A patent/HUE045532T2/hu unknown
- 2016-01-29 CA CA2975372A patent/CA2975372C/en active Active
- 2016-01-29 ES ES16743556T patent/ES2734364T3/es active Active
- 2016-01-29 WO PCT/JP2016/052732 patent/WO2016121953A1/ja active Application Filing
- 2016-10-19 US US15/297,196 patent/US9782412B2/en active Active
2017
- 2017-07-24 PH PH12017501336A patent/PH12017501336A1/en unknown

Also Published As

Publication number	Publication date
DK3120852T3 (da)	2019-07-29
CN107206001B (zh)	2021-09-28
CN113768935A (zh)	2021-12-10
EP3120852A1 (en)	2017-01-25
BR112017016278A2 (pt)	2018-03-27
RU2017127126A (ru)	2019-03-01
CN107206001A (zh)	2017-09-26
BR112017016278B1 (pt)	2022-05-10
TWI638817B (zh)	2018-10-21
MY197518A (en)	2023-06-19
ES2734364T3 (es)	2019-12-05
TR201910158T4 (tr)	2019-07-22
RU2705154C2 (ru)	2019-11-05
CN113768935B (zh)	2024-10-01
KR20170083640A (ko)	2017-07-18
MX2017009863A (es)	2017-11-15
HUE045532T2 (hu)	2020-01-28
SG11201704430SA (en)	2017-08-30
AU2016213030B2 (en)	2019-01-31
US20170042900A1 (en)	2017-02-16
CA2975372A1 (en)	2016-08-04
WO2016121953A1 (ja)	2016-08-04
TW201632526A (zh)	2016-09-16
JP6093485B2 (ja)	2017-03-08
PL3120852T3 (pl)	2019-09-30
JPWO2016121953A1 (ja)	2017-04-27
AU2016213030A1 (en)	2017-06-22
EP3120852B1 (en)	2019-05-01
PT3120852T (pt)	2019-07-16
CA2975372C (en)	2020-01-14
US9782412B2 (en)	2017-10-10
PH12017501336A1 (en)	2017-12-11
EP3120852A4 (en)	2017-05-24
RU2017127126A3 (pl)	2019-03-01

Publication	Publication Date	Title
KR101828187B1 (ko)	2018-02-09	신규 축합 피리미딘 화합물 또는 그 염
EP3269370B1 (en)	2020-01-08	Novel condensed pyrimidine compound or salt thereof
RU2729636C2 (ru)	2020-08-11	Конденсированное пиримидиновое соединение или его соль
US8026246B2 (en)	2011-09-27	Aurora kinase inhibitors for inhibiting mitotic progression
KR20180041757A (ko)	2018-04-24	신규한 피라졸로[3,4-d]피리미딘 화합물 또는 그 염
CN110167941B (zh)	2023-04-04	取代的稠合杂芳基化合物作为激酶抑制剂及其应用
KR101858421B1 (ko)	2018-05-15	면역 질환의 예방 및/또는 치료제

Legal Events

Date	Code	Title
2017-07-04	A201	Request for examination
2017-07-04	A302	Request for accelerated examination
2017-09-20	E902	Notification of reason for refusal
2018-03-26	E701	Decision to grant or registration of patent right
2018-05-09	GRNT	Written decision to grant